OSTX
OS Therapies
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
OSTX Profile
Os Therapies Incorporated
A clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors
Biological Technology
04/12/2018
08/01/2024
American Stock Exchange
4
12-31
Common stock
115 Pullman Crossing Road, Suite 103 , Grasonville, Maryland 21638
--
OS Therapies Incorporated was incorporated in Delaware on April 12, 2018. The Company is a clinical-stage biopharmaceutical company focused on the identification, development and commercialization of osteosarcoma and other solid tumor treatments. They are currently seeking to respond to the call for new therapies with their main core product candidate, OST-HER2 (also known as OST31-164). They intend to use this product candidate to expand their pipeline from osteosarcoma to other solid tumors with the same mechanism of recurrence, including breast, esophageal and lung cancer.